ATE201687T1 - Galanthamin-derivat, ein verfahren zu seiner herstellung und seine verwendung als medikament - Google Patents

Galanthamin-derivat, ein verfahren zu seiner herstellung und seine verwendung als medikament

Info

Publication number: ATE201687T1
Authority: AT; Austria
Prior art keywords: galanthamin; medication; derivative; production; alkylaminocarbonyloxy
Prior art date: 1993-10-15

Application number

AT94115960T

Other languages

English (en)

Inventor

Raymond W Kosley Jr

Larry Davis

Veronica Taberna

Original Assignee

Aventis Pharma Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-10-15

Filing date

1994-10-10

Publication date

2001-06-15

1994-10-10 Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc

2001-06-15 Application granted granted Critical

2001-06-15 Publication of ATE201687T1 publication Critical patent/ATE201687T1/de

Links

229940079593 drug Drugs 0.000 title 1
239000003814 drug Substances 0.000 title 1
ASUTZQLVASHGKV-UHFFFAOYSA-N galanthamine hydrochloride Natural products O1C(=C23)C(OC)=CC=C2CN(C)CCC23C1CC(O)C=C2 ASUTZQLVASHGKV-UHFFFAOYSA-N 0.000 title 1
125000005195 alkyl amino carbonyloxy group Chemical group 0.000 abstract 3
125000004457 alkyl amino carbonyl group Chemical group 0.000 abstract 2
125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
125000004448 alkyl carbonyl group Chemical group 0.000 abstract 1
125000003118 aryl group Chemical group 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
125000001475 halogen functional group Chemical group 0.000 abstract 1
229910052739 hydrogen Inorganic materials 0.000 abstract 1
239000001257 hydrogen Substances 0.000 abstract 1
125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Neurosurgery (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Hospice & Palliative Care (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Psychiatry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

AT94115960T 1993-10-15 1994-10-10 Galanthamin-derivat, ein verfahren zu seiner herstellung und seine verwendung als medikament ATE201687T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US08/137,443 US6323196B1 (en)	1993-10-15	1993-10-15	Galanthamine derivatives as acetylcholinesterase inhibitors

Publications (1)

Publication Number	Publication Date
ATE201687T1 true ATE201687T1 (de)	2001-06-15

Family

ID=22477457

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT94115960T ATE201687T1 (de)	1993-10-15	1994-10-10	Galanthamin-derivat, ein verfahren zu seiner herstellung und seine verwendung als medikament

Country Status (24)

Country	Link
US (1)	US6323196B1 (de)
EP (2)	EP1020469A3 (de)
JP (1)	JP2718637B2 (de)
KR (1)	KR100189043B1 (de)
CN (1)	CN1039011C (de)
AT (1)	ATE201687T1 (de)
AU (1)	AU679560B2 (de)
CA (1)	CA2118171C (de)
CZ (1)	CZ283561B6 (de)
DE (1)	DE69427332T2 (de)
DK (1)	DK0648771T3 (de)
EG (1)	EG20747A (de)
ES (1)	ES2158876T3 (de)
FI (1)	FI108724B (de)
GR (1)	GR3036068T3 (de)
IL (1)	IL111273A (de)
NO (1)	NO307463B1 (de)
NZ (1)	NZ264681A (de)
PL (1)	PL177754B1 (de)
PT (1)	PT648771E (de)
RO (1)	RO114132B1 (de)
RU (1)	RU2113438C1 (de)
TW (1)	TW375615B (de)
ZA (1)	ZA948060B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AT403803B (de)	1996-04-19	1998-05-25	Sanochemia Ltd	Neue benzazepinderivate, diese enthaltende arzneimittel und verwendung derselben zum herstellen von arzneimitteln
JP5558648B2 (ja)	1998-11-23	2014-07-23	デイビス、ボニー	アセチルコリンエステラーゼ阻害剤のための投与製剤
OA11740A (en)	1998-12-24	2005-05-13	Janssen Pharmaceutica Nv	Controlled release galantamine composition.
MXPA02005667A (es) *	1999-12-10	2004-09-10	Bonnie Davis	Analogos de galantamina y licoramina como moduladores de los receptores nicotinicos.
JP2003529602A (ja)	2000-03-31	2003-10-07	ザノヒェミア・ファルマツォイティカ・アーゲー	ガランタミンの新規誘導体および類似体
US20030162770A1 (en) *	2002-02-22	2003-08-28	Davis Bonnie M.	Use of modulators of nicotinic receptors for treatment of cognitive dysfunction
WO2004041281A1 (en) *	2002-11-01	2004-05-21	Oregon Health And Science University	Treatment of hyperkinetic movement disorder with donepezil
US20050048543A1 (en) *	2003-07-11	2005-03-03	Jeroen Aerssens	CHRNA2 genetic markers associated with galantamine response
WO2005042762A2 (en) *	2003-10-28	2005-05-12	Genaissance Pharmaceuticals, Inc.	Lrpap1 genetic markers associated with galantamine response
US20050143350A1 (en) *	2003-11-19	2005-06-30	Seed John C.	Combination drug therapy to treat obesity
US7250258B2 (en) *	2003-12-15	2007-07-31	Pgxhealth Llc	CDK5 genetic markers associated with galantamine response
US20050142193A1 (en) *	2003-12-31	2005-06-30	Lijuan Tang	Galantamine formulations
CA2551946A1 (en) *	2003-12-31	2005-07-21	Actavis Group Hf	Immediate, controlled and sustained release formulations of galantamine
US20080045500A1 (en) *	2004-07-01	2008-02-21	Eisai R&D Management Co., Ltd.	Nerve Regeneration Stimulator
DE602006016441D1 (de) *	2005-05-13	2010-10-07	Alza Corp	Mehrlagiges arzneimittelausbringsystem mit sperre gegen reservoirmaterialfluss
US20080188510A1 (en) *	2005-05-23	2008-08-07	Eisai R & D Management Co., Ltd.	Novel methods using zonisamide
US20090253654A1 (en)	2005-09-22	2009-10-08	Galantos Pharma Gmbh	Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment
EP1777222A1 (de) *	2005-09-22	2007-04-25	Galantos Pharma GmbH	Cholinesterase Inhibitoren mit erhöter Blut Hirn Schranke Permeabilität zur Behandlung von kognitiven Störungen
WO2007035941A2 (en) *	2005-09-23	2007-03-29	Alza Corporation	Transdermal galantamine delivery system
KR100786371B1 (ko) *	2006-12-07	2007-12-17	한국화학연구원	갈란타민의 제조방법
CN102007129B (zh)	2008-04-14	2014-05-07	神经动力生命科学公司	用作治疗人类脑疾病的前药的雪花胺衍生物
JP2013500268A (ja) *	2009-07-23	2013-01-07	シャイアエルエルシー	ガランタミンアミノ酸およびペプチドプロドラッグならびにその使用
US12551491B1 (en) *	2025-07-23	2026-02-17	Alpha Cognition Inc.	Dosage regimens for benzgalantamine

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL122665B1 (en)	1978-11-21	1982-08-31	Edinen Zentar Chim	Process for preparing novel dienones of narvedine type and their derivatives
US4663318A (en)	1986-01-15	1987-05-05	Bonnie Davis	Method of treating Alzheimer's disease
US6150354A (en) *	1987-01-15	2000-11-21	Bonnie Davis	Compounds for the treatment of Alzheimer's disease
KR100195399B1 (ko) *	1987-05-04	1999-06-15	보니데이비스	알쯔하이머 병 치료용 의약
NL8800350A (nl)	1988-02-12	1989-09-01	Stichting Biomedical Research	Synthetische galanthamine-derivaten, werkwijze voor het bereiden daarvan, en farmaceutische samenstellingen.
US5336675A (en) *	1991-05-14	1994-08-09	Ernir Snorrason	Method of treating mania in humans
DE69229781T2 (de)	1991-05-14	2000-01-05	Ernir Snorrason	Behandlung des ermüdungssyndroms mit cholinesteraseinhibitoren
US5231093A (en) *	1991-10-01	1993-07-27	Hoechst-Roussel Pharmaceuticals Incorporated	Carbamate derivatives of 4-amino-3-isoxazolidinones, 3-amino-1-hydroxypyrrolidin-2-ones and 1-amino-1-cyclopropanecarboxylic acid analogs
US5153193A (en)	1991-10-01	1992-10-06	Hoechst-Roussel Pharmaceuticals Incorporated	Carbamate derivatives of 4-amino-3-isoxazolidinones, 3-amino-1-hydroxypyrrolidin-2-ones and 1-amino-1-cyclopropanecarboxylic acid analogs

1993
- 1993-10-15 US US08/137,443 patent/US6323196B1/en not_active Expired - Lifetime
1994
- 1994-10-10 DE DE69427332T patent/DE69427332T2/de not_active Expired - Lifetime
- 1994-10-10 EP EP00107569A patent/EP1020469A3/de not_active Withdrawn
- 1994-10-10 DK DK94115960T patent/DK0648771T3/da active
- 1994-10-10 AT AT94115960T patent/ATE201687T1/de active
- 1994-10-10 PT PT94115960T patent/PT648771E/pt unknown
- 1994-10-10 ES ES94115960T patent/ES2158876T3/es not_active Expired - Lifetime
- 1994-10-10 EP EP94115960A patent/EP0648771B1/de not_active Expired - Lifetime
- 1994-10-12 EG EG63794A patent/EG20747A/xx active
- 1994-10-13 FI FI944822A patent/FI108724B/fi not_active IP Right Cessation
- 1994-10-13 IL IL111273A patent/IL111273A/en not_active IP Right Cessation
- 1994-10-13 NZ NZ264681A patent/NZ264681A/en not_active IP Right Cessation
- 1994-10-13 RU RU94036761A patent/RU2113438C1/ru active
- 1994-10-14 CZ CZ942547A patent/CZ283561B6/cs not_active IP Right Cessation
- 1994-10-14 RO RO94-01668A patent/RO114132B1/ro unknown
- 1994-10-14 KR KR1019940026304A patent/KR100189043B1/ko not_active Expired - Lifetime
- 1994-10-14 CA CA002118171A patent/CA2118171C/en not_active Expired - Lifetime
- 1994-10-14 TW TW083109528A patent/TW375615B/zh not_active IP Right Cessation
- 1994-10-14 AU AU75812/94A patent/AU679560B2/en not_active Expired
- 1994-10-14 ZA ZA948060A patent/ZA948060B/xx unknown
- 1994-10-14 NO NO943894A patent/NO307463B1/no not_active IP Right Cessation
- 1994-10-14 PL PL94305455A patent/PL177754B1/pl unknown
- 1994-10-14 CN CN94117061A patent/CN1039011C/zh not_active Expired - Lifetime
- 1994-10-17 JP JP6250776A patent/JP2718637B2/ja not_active Expired - Fee Related
2001
- 2001-06-19 GR GR20010400911T patent/GR3036068T3/el unknown

Also Published As

Publication number	Publication date
ES2158876T3 (es)	2001-09-16
NZ264681A (en)	1997-12-19
RU2113438C1 (ru)	1998-06-20
NO307463B1 (no)	2000-04-10
RO114132B1 (ro)	1999-01-29
JPH07188238A (ja)	1995-07-25
CA2118171C (en)	1999-12-28
EP1020469A2 (de)	2000-07-19
PT648771E (pt)	2001-09-28
FI944822L (fi)	1995-04-16
KR950011444A (ko)	1995-05-15
DK0648771T3 (da)	2001-08-27
AU7581294A (en)	1995-05-04
ZA948060B (en)	1995-06-09
DE69427332T2 (de)	2001-10-11
NO943894D0 (no)	1994-10-14
IL111273A0 (en)	1994-12-29
NO943894L (no)	1995-04-18
CN1039011C (zh)	1998-07-08
PL177754B1 (pl)	2000-01-31
CZ254794A3 (en)	1995-05-17
AU679560B2 (en)	1997-07-03
GR3036068T3 (en)	2001-09-28
CN1108658A (zh)	1995-09-20
RU94036761A (ru)	1996-09-10
PL305455A1 (en)	1995-04-18
EP1020469A3 (de)	2000-07-26
EP0648771B1 (de)	2001-05-30
FI108724B (fi)	2002-03-15
US6323196B1 (en)	2001-11-27
CZ283561B6 (cs)	1998-05-13
IL111273A (en)	1998-04-05
FI944822A0 (fi)	1994-10-13
KR100189043B1 (ko)	1999-06-01
JP2718637B2 (ja)	1998-02-25
EP0648771A1 (de)	1995-04-19
TW375615B (en)	1999-12-01
EG20747A (en)	2000-01-31
DE69427332D1 (de)	2001-07-05
CA2118171A1 (en)	1995-04-16

Legal Events

Date	Code	Title	Description
2001-08-15	UEP	Publication of translation of european patent specification
2011-09-15	EEIH	Change in the person of patent owner

Publication	Publication Date	Title
ATE201687T1 (de)	2001-06-15	Galanthamin-derivat, ein verfahren zu seiner herstellung und seine verwendung als medikament
ATE212348T1 (de)	2002-02-15	Galanthamin derivate, ein verfahren zu ihrer herstellung und ihre verwendung als medikamente
AU3648393A (en)	1993-10-21	Depsipeptide derivative, production thereof and use thereof
ATE282020T1 (de)	2004-11-15	Verfahren zur herstellung von 2-aminomalonsäure- derivaten
DE50011034D1 (de)	2005-09-29	N-substituierte 4-aminopteridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ATE242241T1 (de)	2003-06-15	Imidazopyridinderivate und verfahren zu ihrer herstellung
DE69231874D1 (de)	2001-07-19	Verfahren zur herstellung von 4-substituierten azetidinon-derivaten
ATE164582T1 (de)	1998-04-15	1-methylcarbapenemderivate und verfahren zu ihrer herstellung
ATE211474T1 (de)	2002-01-15	Galanthamin derivate, verfahren zu ihrer herstellung und ihre verwendung als medikamente
DK0559533T3 (da)	1998-12-14	Fremgangsmåde til fremstilling af beta-lactamderivat og syntetisk mellemprodukt deraf
ATE214061T1 (de)	2002-03-15	Azetidinonverbindung und verfahren zu ihrer herstellung
DE3864707D1 (de)	1991-10-17	Benzoxazin-derivate und verfahren zu ihrer herstellung.
ATE191461T1 (de)	2000-04-15	Verfahren zur herstellung von alkoxyimino acetamid-derivaten
EP0555479A4 (de)	1994-02-09
TW350835B (en)	1999-01-21	Process for preparing nitroaniline derivatives
ATE402940T1 (de)	2008-08-15	Verfahren zur herstellung von 3-cephem- verbindungen
ATE189887T1 (de)	2000-03-15	Vitamin-d-derivat und verfahren zu seiner herstellung
ATE189453T1 (de)	2000-02-15	Verfahren zur herstellung von 2-cyanobiphenyl- verbindungen
DE3884518D1 (de)	1993-11-04	Naphthothiazepin-derivate und verfahren zu ihrer herstellung.
DE69311999D1 (de)	1997-08-14	Verfahren zur Herstellung von Amino-Thiadiazolylacetylhaliden
ATE67194T1 (de)	1991-09-15	Thiadiazolylacetamid-derivate, verfahren zu ihrer herstellung und ihre verwendung.
ATE139767T1 (de)	1996-07-15	Verfahren zur herstellung 5-pyrazolomerkaptan- derivate und dessen zwischenprodukte
DE50000575D1 (de)	2002-11-07	Verfahren zur Herstellung von Folsäure
ATE258545T1 (de)	2004-02-15	Antioxidantien, verfahren zu ihrer herstellung und ihre verwendungen
DE69628887D1 (de)	2003-08-07	Verfahren zur herstellung von beta-lactamderivaten